MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Get insights on Klippel-Feil Syndrome 1, its diagnosis through clinical evaluation, imaging, and genetic testing. Learn about management, family planning, and future therapies.
Explore the diagnosis, genetic testing, and management of Lattice Corneal Dystrophy Type I. Learn about early detection, family counseling, and innovative treatments.
Genetic testing for Leri-Weill Dyschondrosteosis aids in accurate diagnosis, personalized treatment, and informed family planning for this rare bone growth disorder.
Genetic testing for Leukocyte Adhesion Deficiency 1 (LAD-1) diagnoses DNA mutations, guides treatment like stem cell transplantation, and aids in family planning decisions.
Explore Lewy Body Dementia, its symptoms, and diagnosis. Learn how genetic testing identifies risk and personalizes treatment for better management of this condition.
Lung cancer remains one of the most common and deadly cancers worldwide, affecting millions of individuals each year.
Lynch syndrome genetic testing: Learn how early diagnosis, family history, clinical evaluation, and personalized cancer screening can manage risk effectively.
Discover how genetic testing aids in diagnosing malignant breast tumors, understanding risk factors, and guiding personalized treatment plans for improved outcomes.